NCT07163676

Brief Summary

glaucoma is prevalent between elders. Baduanjin exercise is a suitable exercise for elders. elders with glaucoma will divided to group I or group II. each/every group will contain 30 elders. group I will receive baduanjin exercise for 60 minutes every day ((except fridays) for eight weeks. group II will act as waistlist.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 11, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 2, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 9, 2025

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

September 9, 2025

Status Verified

September 1, 2025

Enrollment Period

5 months

First QC Date

September 2, 2025

Last Update Submit

September 2, 2025

Conditions

Glaucoma

Outcome Measures

Primary Outcomes (1)

  • intraocular pressure

    it will be assessed in both eyes

    it will be measured after 8 weeks

Secondary Outcomes (5)

  • patient health questionnaire

    it will be measured after 8 weeks

  • National Eye Institute Visual Function Questionnaire

    it will be measured after 8 weeks

  • Glaucoma-related quality of life questionnaire

    it will be measured after 8 weeks

  • State trait anxiety inventory

    it will be measured after 8 weeks

  • Stress vulnerability scale

    it will be measured after 8 weeks

Study Arms (2)

group number 1

EXPERIMENTAL

group I will receive baduanjin exercise for 60 minutes every day ((except fridays) for eight weeks.

Behavioral: Baduanjin exercise

group number 2

NO INTERVENTION

group II will act as waistlist.

Interventions

Baduanjin exerciseBEHAVIORAL

group I will receive baduanjin exercise for 60 minutes every day ((except fridays) for eight weeks.

group number 1

Eligibility Criteria

Age65 Years - 75 Years
Sexall(Gender-based eligibility)
Gender Eligibility Detailsbased on self-representation of gender identity.
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • high-tension primary open angle glaucoma (bilateral)
  • ocular hypertension in both eyes

You may not qualify if:

  • cataract
  • diabetes
  • cardiac disorders
  • obesity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Giza, Dokki, Egypt

RECRUITING

MeSH Terms

Conditions

Glaucoma

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Study Officials

  • Ali MA Ismail, lecturer

    Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ali MA Ismail, lecturer

CONTACT

01005154209ali.mohamed@pt.cu.edu.eg

ali mohamed, lecturer

CONTACT

allooka2012@gmail.com

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of physical therapy for Cardiovascular, Respiratory disorder and Geriatrics, Faculty of Physical Therapy, Cairo University

Study Record Dates

First Submitted

September 2, 2025

First Posted

September 9, 2025

Study Start

May 11, 2025

Primary Completion

October 1, 2025

Study Completion

October 1, 2025

Last Updated

September 9, 2025

Record last verified: 2025-09

Locations

EG(1)